| Gene symbol | IFNB1 | Synonyms | IFB, IFF, IFN-beta, IFNB | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9p21.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | interferon beta 1 | ||||
| GTO ID | GTC1192 |
| Trial ID | NCT00031083 |
| Disease | Anaplastic Astrocytoma | Brain Glioblastoma Multiforme |
| Altered gene | IFNB1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | BG00001|IDEC-201 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Multi-center, Open Label, Two Part, Dose Escalation Study to Determine the Tolerability of Interferon-Beta Gene Transfer (BG00001) in the Treatment of Recurrent or Progressive Grade III and Grade IV Gliomas |
| Year | 2002 |
| Country | United States |
| Company sponsor | Biogen |
| Other ID(s) | C-1502|0101-453 |
| Vector information | |||||||||||||
|
|||||||||||||
| Cohort 1 | |||||||
|
|||||||